大幅增发新股,北京药企诺诚健华引入高瓴资本战略投资

腾讯自选股
03 Feb 2021

原标题:大幅增发新股,北京药企诺诚健华引入高瓴资本战略投资 来源:北京日报客户端2月3日北京生物医药高科技公司诺诚健华披露,其与高瓴资本以及维梧资本旗下的相关机构签署认购协议,由高瓴资本与维梧资本认购其定向增发的约2.1亿股新股份。而这一引入战略投资的行动也显示了资本市场对诺诚健华自主创新能力的认可。据介绍,这相当于截至当天诺诚健华现有已发行股份总额的约16.33%,认购价为每股14.45港元。这...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10